Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tongyao Pharmaceutical Group Stock Co., Ltd. is a prominent Chinese pharmaceutical manufacturer and a core subsidiary of the Xiuzheng Pharmaceutical Group. Headquartered in Tonghua, Jilin Province, the company specializes in the research, development, and large-scale production of Traditional Chinese Medicines (TCM) and generic chemical drugs. Its extensive product portfolio spans multiple therapeutic areas, including gastroenterology, respiratory health, dermatology, and gynecology, with flagship products such as Stashu for gastric relief and various specialized TCM formulations. Tongyao operates advanced GMP-certified facilities and is recognized for its efforts in the modernization of traditional medicine through digital manufacturing and rigorous quality control standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tongyao Pharmaceutical Group.